Pharmacopeia
CEFOTAXIME
Core pharmacology
- Class Group
ANTIBIOTIC:
CEPHALOSPORIN- Legacy Cicm Level
Level 1
- Introduction
3rd Generation Cephalosporin
- Presentation
Powder for IV injection.
Does NOT precipitate in
calcium containing solutions- Mechanism of action
Beta lactam ring binds to multiple penicillin binding proteins (carboxy/endo/ transpeptidase) and
prevents crosslinking of bacterial peptidoglycan
inhibits cell wall synthesis
BROADER SPECTRUMBacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested
Configuration: Stability against Betalactamases
- Onset Peak Duration
1-2g q8hr
- Antimicrobial Spectrum
Bacteriocidal
Active against: same as ceftriaxone
Not Active against: same as ceftriaxone
- Adverse Effects Toxicity
Generally well tolerated
Hypersensitivity reactions (10% cross reactivity with penicillin allergies), thrombophlebitis, interstitial nephritis, low prothrombin, flushing and headaches with EtOH.Third generation cephalosporins are particularly associated with antibiotic associated colitis.
- Absorption
Poor oral absorb – given IV or IM only.
- Distribution
Widely distributed and crosses the BB in meningitis. Good tissue penetration
- Protein binding
35-50% PB
- Metabolism
Active metabolite desacetyl-cefotaxime in the liver
- Excretion
Mainly renal clearance
- Half-life
Plasma T1/2 = 1-1.5 hrs